Revolutionize Disease R&D
MEDEloop is the most valuable database available to
speed disease research and development
Life Sciences
MEDEloop incorporates various modalities of Real World Data (EMR, EHR, whole genome sequences, wearables, lifestyle, metabolomics, proteomics) to transform the drug-development paradigm.
MEDEloop’s robust RWD has applications across the entire drug development life cycle, presenting numerous opportunities for biopharmaceutical companies to shorten development time lines, reduce the costs of clinical trials, and improve the probability of technical and regulatory success (PTRS).
MEDEloop’s platform offers:
-
Direct access to patients seeking to participate in trials
-
Ability to query Regulatory-grade, longitudinal medical records and real world data
-
Analyze natural histories, disease burdens and clinical endpoints
Compliance
MEDEloop uses HITRUST CSF for
compliance with the following standards
21 CFR Part 11
CCPA
FISMA
FedRAMP
ISO 27001
Practices (HICP)
NIST 800-171
NIST 800-53
NIST Cybersecurity Framework
HHS Health Industry Cybersecurity
South Carolina Insurance Data Act
State of Massachusetts Data Protection Act
State of Nevada Security and Privacy Act
THE CHALLENGE
Drug development is constrained by limited understanding of a particular disease. How do you know what endpoint to examine? How do you know what an important effect would be? Without information on the natural history of the disease, it is hard to ascertain how to design a clinical trial. Further, patient identification, screening and enrollment is a failure-prone, burdensome, and lengthy process that slows life-saving therapy development.
.png){kind=small}
Access to comprehensive, actionable data is constrained
Trial enrollment and screening is labour-intensive, arduous, and failure-prone
It’s difficult to ascertain trial feasibility for some diseases
Data is limited to in-clinic data only
THE SOLUTION
The most powerful database dedicated to disease research.
The MEDEloop platform contains longitudinal, continuous data for dozens of patient cohorts; harmonized, structured and visualized all in one place
Database access for querying and patient screening
Direct patient enrollment and recontacting
.png){kind=small}
Regulatory-grade real-world-evidence collection
Post-marketing studies capabilities
Custom-reporting and analysis
